MGC Diagnostics Corporation (MGC), a global medical technology company dedicated to cardiorespiratory health solutions, and a portfolio company of Altus Capital Partners (Altus), has acquired Lemon Medical, a medical technology company, headquartered in Hammelburg, Germany.
Financial terms of the transaction have not been disclosed.
Lemon Medical, a German Limited Liability Company, founded in 2009, specialises in the design, development, production, and distribution of single-patient use disposables. These include viral and bacterial filters designed to protect patients, medical personnel, and diagnostic instruments against cross contamination during cardiorespiratory function testing. The usage of these protective products is experiencing significant growth because of the Covid pandemic and are now globally required patient safety components. In addition to the disposable products, Lemon develops, manufactures, and markets non-invasive diagnostic systems for detecting, classifying, and managing cardiorespiratory disease.
“MGC Diagnostics is excited to further strengthen its in-house manufacturing capabilities, product offering, and European presence through this acquisition of Lemon,” says Greg Greenberg, Co-Founder and Senior Partner of Altus Capital Partners. “We are thrilled about the opportunities this partnership will provide.”
“Following an exhaustive evaluation of the cardiorespiratory disposable filter market, MGC Diagnostics identified Lemon Medical, and its founder, Alfred Albert, as the ideal partner,” says Todd Austin, Chief Executive Officer of MGC. “This is another strategic acquisition for MGC Diagnostics, providing our own source of disposables as well as a significant footprint in the German market, one of the top cardiorespiratory scientific communities in the world.”
